(Q34009823)

30 July 2017

1 reference

title

Antiviral therapy for enteroviruses and rhinoviruses (English)

1 reference

30 July 2017

H A Rotbart

1

1 reference

30 July 2017

1 July 2000

1 reference

Antiviral Chemistry & Chemotherapy

30 July 2017

1 reference

30 July 2017

11

1 reference

30 July 2017

4

1 reference

30 July 2017

261-271

1 reference

Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults.

30 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Age dependence of paralysis induced by echovirus type 9 in infant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Effects of upper respiratory tract infections in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Role of interferon, antibodies and macrophages in the protective effect of Corynebacterium parvum on encephalomyocarditis virus-induced disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Computed tomographic study of the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Three-dimensional structure of poliovirus at 2.9 A resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Neutralizing antibody and interferon-alpha in cerebrospinal fluids and sera of acute aseptic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A/D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Virus-specific, early appearing neutralizing activity and interferon in tears of patients with acute hemorrhagic conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Method for detection of picornavirus capsid binders with soluble intercellular adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Role of soluble cytokines on the restricted replication of poliovirus in the monocytic U937 cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Oral efficacy of WIN 51711 in mice infected with human poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Pathogenesis of coxsackie virus infection; multiplication of virus and evolution of the muscle lesion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Controlled trial of enviroxime against natural rhinovirus infections in a community

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Perinatal echovirus infection: risk of transmission during a community outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Enterovirus infection of the central nervous system of humans: lack of association with chronic neurological disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Respiratory viruses and exacerbations of asthma in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Therapeutic activity of enviroxime against rhinovirus infection in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Virus-Induced Interferon Production in Human Leukocytes: A Low Responder to One Virus Can Be a High Responder to Another Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

A study of the neurological disorder associated with acute haemorrhagic conjunctivitis due to enterovirus 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

Experimental Infection of Gibbons with Rhinovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020001100402

10.1177/095632020001100402

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10950388